CTD (OTCMKTS:CTDH) and Methanex (NASDAQ:MEOH) are both basic materials companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.
This is a summary of recent recommendations for CTD and Methanex, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Valuation & Earnings
This table compares CTD and Methanex’s gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|CTD||$1.01 million||21.94||-$4.26 million||N/A||N/A|
|Methanex||$3.93 billion||0.70||$568.98 million||$6.86||5.30|
Methanex has higher revenue and earnings than CTD.
Institutional & Insider Ownership
65.1% of Methanex shares are held by institutional investors. 36.0% of CTD shares are held by insiders. Comparatively, 1.0% of Methanex shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Methanex pays an annual dividend of $1.44 per share and has a dividend yield of 4.0%. CTD does not pay a dividend. Methanex pays out 21.0% of its earnings in the form of a dividend. Methanex has raised its dividend for 8 consecutive years.
Volatility & Risk
CTD has a beta of 0.19, meaning that its share price is 81% less volatile than the S&P 500. Comparatively, Methanex has a beta of 1.77, meaning that its share price is 77% more volatile than the S&P 500.
This table compares CTD and Methanex’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Methanex beats CTD on 11 of the 14 factors compared between the two stocks.
CTD Company Profile
CTD Holdings, Inc., a biotechnology company, develops cyclodextrin-based products for the treatment of diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug for the treatment of Niemann-Pick Type C disease. The company also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. CTD Holdings, Inc. was founded in 1990 and is based in Gainesville, Florida.
Methanex Company Profile
Methanex Corporation produces and supplies methanol in North America, the Asia Pacific, Europe, and South America. It also purchases methanol produced by others under methanol offtake contracts and on the spot market. The company was founded in 1968 and is headquartered in Vancouver, Canada.
Receive News & Ratings for CTD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CTD and related companies with MarketBeat.com's FREE daily email newsletter.